All In MedTech

Device Trial Radar · NCT03028415

AMPLEX Ankle Fusion and Hindfoot

A Multi-Center, Randomized, Pivotal Study Evaluating AMPLEX Compared To Autogenous Bone Graft in Subjects Indicated for Arthrodesis Surgery Involving the Hindfoot or Ankle

Last checked: Nov 20, 2026Latest source record: Mar 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

56

Actual

Start

Jul 28, 2017

Primary completion

Jan 9, 2020

Study completion Jul 9, 2020

Sponsor

Lead sponsor
Ferring PharmaceuticalsNot on our public-company list
Sponsor type
Industry
First posted
Jan 23, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To demonstrate that AMPLEX is non-inferior to autogenous bone graft (ABG) for bone fusion in a population indicated for single, double, or triple hindfoot arthrodesis or ankle arthrodesis surgery with supplemental graft material.

Conditions

  • Arthrodesis Surgery Involving the Hindfoot or Ankle

Interventions

  • AMPLEXDevice

    A bone graft substitute

  • Autogenous Bone Graft (ABG)Procedure

    Control material administered by surgical implant

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Subjects Who Met All Five Criteria for Subject Performance Composite (SPC) EndpointTime frame: At week 52

Locations

36 sites in 2 countries. Site status is shown where the registry gives one.

  • Physician Research Group

    Gilbert, Arizona

35 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.